CA2582224A1 - Compositions et methodes de modulation de la regeneration des tissus et des reponses chimiotactique - Google Patents

Compositions et methodes de modulation de la regeneration des tissus et des reponses chimiotactique Download PDF

Info

Publication number
CA2582224A1
CA2582224A1 CA002582224A CA2582224A CA2582224A1 CA 2582224 A1 CA2582224 A1 CA 2582224A1 CA 002582224 A CA002582224 A CA 002582224A CA 2582224 A CA2582224 A CA 2582224A CA 2582224 A1 CA2582224 A1 CA 2582224A1
Authority
CA
Canada
Prior art keywords
ccn3
patient
polypeptide
wound healing
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002582224A
Other languages
English (en)
Inventor
Lester F. Lau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2582224A1 publication Critical patent/CA2582224A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
CA002582224A 2004-09-28 2005-09-28 Compositions et methodes de modulation de la regeneration des tissus et des reponses chimiotactique Abandoned CA2582224A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US61521304P 2004-09-28 2004-09-28
US60/615,213 2004-09-28
PCT/US2005/034593 WO2006036962A2 (fr) 2004-09-28 2005-09-28 Compositions et methodes de modulation de la regeneration des tissus et des reponses chimiotactique

Publications (1)

Publication Number Publication Date
CA2582224A1 true CA2582224A1 (fr) 2006-04-06

Family

ID=36119532

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002582224A Abandoned CA2582224A1 (fr) 2004-09-28 2005-09-28 Compositions et methodes de modulation de la regeneration des tissus et des reponses chimiotactique

Country Status (2)

Country Link
CA (1) CA2582224A1 (fr)
WO (1) WO2006036962A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7780949B2 (en) 2005-01-10 2010-08-24 Rosalind Franklin University Of Medicine And Science Regulation of CCN2 by CCN3 and its therapeutic and diagnostic potential in fibrosis, sclerosis and other diseases
JP4834677B2 (ja) * 2005-01-10 2011-12-14 ロザリンド フランクリン ユニバーシティー オブ メディスン アンド サイエンス Ｃｃｎ３によるｃｃｎ２の調節ならびに線維症、硬化症および他の疾患におけるその治療的可能性ならびに診断的可能性
EP2552462B1 (fr) * 2010-04-02 2015-12-16 Rosalind Franklin University of Medicine and Science Peptides ccn3 à visée thérapeutique et leurs analogues
US9114112B2 (en) * 2010-04-02 2015-08-25 Rosalind Franklin University Of Medicine And Science CCN3 and CCN3 peptides and analogs thereof for therapeutic uses
WO2011134063A1 (fr) * 2010-04-26 2011-11-03 UNIVERSITé LAVAL Ccn3 et ses utilisations contre des troubles associés au syndrome métabolique
US10028906B2 (en) 2016-03-22 2018-07-24 Rosalind Franklin University Of Medicine And Science Method and kit for treating a solid tumor and associated desmoplasia

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7780949B2 (en) * 2005-01-10 2010-08-24 Rosalind Franklin University Of Medicine And Science Regulation of CCN2 by CCN3 and its therapeutic and diagnostic potential in fibrosis, sclerosis and other diseases

Also Published As

Publication number Publication date
WO2006036962A3 (fr) 2007-08-23
WO2006036962A2 (fr) 2006-04-06

Similar Documents

Publication Publication Date Title
AU670770B2 (en) Inhibiting transforming growth factor beta to prevent accumulation of extracellular matrix
Li et al. Hepatocyte growth factor and hepatocyte growth factor receptor in the lacrimal gland, tears, and cornea.
EP0809517B1 (fr) Therapie genique anti-facteur de croissance transformant beta
EP1061944B1 (fr) Antagonistes therapeutiques du recepteur de chemokine
EP1259248B1 (fr) Procedes de traitement de cancers exprimant le facteur d de croissance endotheliale vasculaire
EP2739645B1 (fr) Anticorps specifiques d'endogline pur l'utilisation dans le traitement d'insuffisance cardiaque et d'états associés
JPH0780780B2 (ja) 細胞外マトリックスの蓄積防止のためのトランスフォーミング増殖因子βの阻害
NO329695B1 (no) Anvendelse av syklisk RGD pentapeptid antagonist til αv integriner
WO1998012226A9 (fr) Procede permettant de freiner l'evolution des cancers et d'inhiber l'angiogenese a l'aide de fibronectine
US20060040253A1 (en) Use of Smad3 inhibitor in the treatment of fibrosis dependent on epithelial to mesenchymal transition as in the eye and kidney
EP2548579A1 (fr) Cibler la régulation du VEGF-B des transporteurs d'acides gras afin de moduler les maladies humaines
WO1998012226A1 (fr) Procede permettant de freiner l'evolution des cancers et d'inhiber l'angiogenese a l'aide de fibronectine
CA2582224A1 (fr) Compositions et methodes de modulation de la regeneration des tissus et des reponses chimiotactique
EP2155234A1 (fr) Thérapie combinée pour les ulcères dermiques chroniques
AU2003206865B2 (en) A novel target to inhibit angiogenesis
WO1999059614A1 (fr) Modulation de l'angiogenese et de la cicatrisation
WO1999036103A1 (fr) Prevention et traitement de la neuropathie au moyen du facteur de croissance d'hepatocytes
JP4094814B2 (ja) 血管新生抑制剤
US20100292300A1 (en) Compositions and methods for inhibiting or reversing fibrotic disorders
US6846647B1 (en) Polypeptides suppressing smooth muscle cell proliferation, the encoding cDNA, and related methods
KR20070001995A (ko) 세포외 매트릭스 축적의 치료 또는 예방법
EP2500351B1 (fr) Domaine LG3 de la chaîne alpha-2 laminine humaine et peptides actifs favorisant l'adhésion cellulaire, la prolifération, la migration et l'excroissance de neurites
CN108697772B (zh) 用于治疗视网膜病的组合物和方法
US20200062855A1 (en) Compositions and methods of promoting wound healing
US20060216237A1 (en) Inhibition of angiogenesis and tumor development by IGFBP-4

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued

Effective date: 20140305